HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business sectors: Raw Material Medicine, Finished Medicine, and Food/Health Functional Food Raw Materials. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory and others. The company was founded on November 18, 1980 and is headquartered in Hwaseong-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company